Pulmonx Total Current Liabilities 2019-2025 | LUNG

Pulmonx total current liabilities from 2019 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Pulmonx Annual Total Current Liabilities
(Millions of US $)
2024 $24
2023 $23
2022 $18
2021 $18
2020 $13
2019 $14
2018 $8
Pulmonx Quarterly Total Current Liabilities
(Millions of US $)
2025-03-31 $25
2024-12-31 $24
2024-09-30 $18
2024-06-30 $16
2024-03-31 $21
2023-12-31 $23
2023-09-30 $20
2023-06-30 $20
2023-03-31 $17
2022-12-31 $18
2022-09-30 $22
2022-06-30 $20
2022-03-31 $18
2021-12-31 $18
2021-09-30 $22
2021-06-30 $16
2021-03-31 $14
2020-12-31 $13
2020-09-30 $15
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2018-12-31 $8
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.126B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.332B 57.93
Hims & Hers Health (HIMS) United States $12.707B 132.02
Tempus AI (TEM) United States $10.988B 0.00
IRhythm Technologies (IRTC) United States $4.490B 0.00
Inspire Medical Systems (INSP) United States $3.944B 61.63
Hinge Health (HNGE) United States $3.156B 0.00
Privia Health (PRVA) United States $2.783B 190.25
Enovis (ENOV) United States $1.694B 9.44
Clover Health Investments (CLOV) United States $1.613B 0.00
Schrodinger (SDGR) United States $1.592B 0.00
Phreesia (PHR) United States $1.482B 0.00
Omnicell (OMCL) United States $1.415B 24.96
Azenta (AZTA) United States $1.219B 56.66
10x Genomics (TXG) United States $1.164B 0.00
Fulgent Genetics (FLGT) United States $0.629B 0.00
Claritev (CTEV) United States $0.629B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.561B 167.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.357B 791.67
Outset Medical (OM) United States $0.316B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.194B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.129B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
American Well (AMWL) United States $0.103B 0.00
CareCloud (CCLD) United States $0.085B 3.26
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
P3 Health Partners (PIII) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.034B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00